Jennifer K. Moses
2021
In 2021, Jennifer K. Moses earned a total compensation of $1.5M as Former Chief Financial Officer at G1 Therapeutics, a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,268 |
|---|---|
| Option Awards | $706,966 |
| Salary | $443,300 |
| Stock Awards | $198,770 |
| Other | $8,700 |
| Total | $1,512,004 |
Moses received $707K in option awards, accounting for 47% of the total pay in 2021.
Moses also received $154.3K in non-equity incentive plan, $443.3K in salary, $198.8K in stock awards and $8.7K in other compensation.
Rankings
In 2021, Jennifer K. Moses' compensation ranked 7,227th out of 12,415 executives tracked by ExecPay. In other words, Moses earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,227 out of 12,415 | 42nd |
Division Manufacturing | 3,169 out of 5,505 | 42nd |
Major group Chemicals And Allied Products | 1,400 out of 2,375 | 41st |
Industry group Drugs | 1,247 out of 2,096 | 41st |
Industry Pharmaceutical Preparations | 915 out of 1,546 | 41st |
Source: SEC filing on April 26, 2023.
Moses' colleagues
We found two more compensation records of executives who worked with Jennifer K. Moses at G1 Therapeutics in 2021.